Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHIT1 | Q13231 | 15/20 | 0.71 |
| ▸ | KCNH2 | Q12809 | 10/20 | 0.71 |
| ▸ | CHIA | Q9BZP6 | 5/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22903462 | 1.00 | CHIT1 (0.71) | CHIT1KCNH2CHIASLC6A3 | |
| SCHEMBL22901758 | 0.93 | KCNH2 (0.71) | CHIT1KCNH2CHIASLC6A3 | |
| SCHEMBL22903470 | 0.93 | KCNH2 (0.71) | CHIT1KCNH2CHIASLC6A3 | |
| Trifluoroacetic Acid SCHEMBL28709526 | 0.92 | CHIT1 (0.61) | CHIT1KCNH2CHIASLC6A3 | |
| SCHEMBL22901761 | 0.88 | CHIT1 (0.71) | CHIT1KCNH2CHIASLC6A3 | |
| Hydrochloric Acid SCHEMBL29789372 | 0.88 | CHIT1 (0.70) | CHIT1KCNH2CHIASLC6A3 | |
| SCHEMBL22901835 | 0.86 | KCNH2 (0.59) | CHIT1KCNH2CHIASLC6A3 | |
| Trifluoroacetic Acid SCHEMBL28702259 | 0.85 | KCNH2 (0.61) | CHIT1KCNH2CHIASLC6A3 | |
| SCHEMBL18577283 | 0.84 | CHIT1 (0.69) | CHIT1KCNH2CHIA | |
| SCHEMBL20628938 | 0.84 | CHIT1 (0.69) | CHIT1KCNH2CHIA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11638707-B2 | Substituted amino triazoles useful as chitinase inhibitors | MOLECURE S.A. (PL) | 2023-05-02 | — | — | US | disclosed |
| US-11638707-B2 | Substituted amino triazoles useful as chitinase inhibitors | MOLECURE S.A. (PL) | 2023-05-02 | — | — | US | disclosed |
| US-20210015822-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS CHITINASE INHIBITORS | GALAPAGOS NV (BE) | 2021-01-21 | — | — | US | disclosed |
| WO-2021009209-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS CHITINASE INHIBITORS | Oncoarendi Therapeutics S.A. (PL) | 2021-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210015822-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS CHITINASE INHIBITORS | CHIT1, CHIA, CHI3L1 | CHIT1 1/4885KCNH2 3849/4885CHIA 2/4885 |
| US-11638707-B2 | Substituted amino triazoles useful as chitinase inhibitors | CHIT1, CHIA, CHI3L1 | CHIT1 1/4885KCNH2 3849/4885CHIA 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.